Press releases

IACTA Pharmaceuticals and Pharmaleads to Develop the World’s First Epithelial Protective Drug Harnessing Endogenous Analgesia for the Topical Treatment of Acute and Chronic Ocular Pain

Ocular Pain, a $10+ billion global market, with significant unmet medical need License agreement aims to accelerate global development of DENKIs, leveraging expertise and resources of both companies IRVINE, Calif., PARIS, France, and HONG KONG, China, January 7, 2021 – IACTA Pharmaceuticals, Inc. (“IACTA”) and Pharmaleads, with Pharmaleads Greater China, today announced they have entered […] Read full post »

IACTA Pharmaceuticals et Pharmaleads s’allient dans le développement du premier médicament, exploitant le système antalgique endogène, pour le traitement topique des douleurs oculaires aiguës et chroniques

La douleur oculaire représente un marché global de plus de 10 milliards US $ aux besoins médicaux non satisfaits Grâce à l’expertise et aux ressources des deux sociétés, cet accord de licence permettra l’accélération du développement mondial des DENKI® IRVINE, Californie, PARIS, France, et Hong Kong, Chine, le 7 janvier 2021 — IACTA Pharmaceuticals, Inc. […] Read full post »

Promotion of a new management team at Pharmaleads to accelerate the development of its pain relief drug candidates

Tanja Ouimet, Chief Operating Officer Hervé Poras, Chief Scientific Officer Paris, January 5, 2021 – Pharmaleads, a biopharmaceutical company specialized in the development of innovative pain relief products, announces the promotion of Tanja Ouimet as Chief Operating Officer and Hervé Poras as Chief Scientific Officer. They are missioned by the Board of Directors to accelerate […] Read full post »

Older posts

Page 1 of 3123
Discover our publications
NEWS RELEASES